亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report

        2021-02-05 03:36:32HengYehChiaJungKuoRenChinWuChienMingChenWenSyTsaiMingYaoSuChengTangChiuPuoHsienLe
        World Journal of Gastroenterology 2021年5期

        Heng Yeh, Chia-Jung Kuo, Ren-Chin Wu, Chien-Ming Chen, Wen-Sy Tsai, Ming-Yao Su, Cheng-Tang Chiu,Puo-Hsien Le

        Abstract

        Key Words: Vedolizumab; Crohn's disease; Rectoprostatic fistula; Rectal pre-sacral fistula; Pre-sacral abscess; Case report

        INTRODUCTION

        Fistula affects up to 50% Crohn’s disease (CD) patients within 20 years of initial diagnosis[1,2]. It includes perianal, rectovaginal, enterocutaneous and internal fistula, but no rectoprostatic fistula or rectopresacral fistula were reported. The treatment of fistula usually requires a combination of medical and surgical approach[3]. As far as medical treatment is concerned, tumor necrosis factor (TNF) antagonists are most effective to treat fistulizing CD[4]. However, some studies also noted the beneficial effect of vedolizumab for fistulizing CD[5,6]. We presented the patient of CD, complicated with rectoprostatic fistula, rectopresacral fistula and presacral abscess. He had complete fistula closure and deep remission after transverse colostomy and vedolizumab treatment for six months.

        CASE PRESENTATION

        Chief complaints

        Low abdominal pain and intermittent bloody stool for 6 mo.

        History of present illness

        A 47-year-old man has decompensated liver cirrhosis, child B, hepatitis C virus (HCV) and alcoholism related, complicated with hypoalbuminemia, hyperbilirubinemia, coagulopathy, thrombocytopenia, splenomegaly and esophageal varices, Form 1. He complained low abdominal pain and intermittent bloody stool for 6 mo. Appendicitis was diagnosed in local hospital, and he received appendectomy on 16thNovember 2019. However, he suffered from progressive low abdominal pain, bloody stool, dizziness, and intermittent fever up to 38 °C for four days. He also mentioned body weight loss 20 kg within one year. He was brought to our emergent department.

        History of past illness

        Decompensated liver cirrhosis, child B, hepatitis C virus infection and alcoholism.

        Personal and family history

        Appendicitis was diagnosed in local hospital, and he received appendectomy on 16thNovember 2019.

        Laboratory examinations

        Lab data revealed hemoglobin 10.1 g/dL, platelet 66000/μL, white blood cell 7700/μL, segment 68.7%, lymphocyte 23.7%, international normalized ratio (INR) 1.5, aspartate aminotransferase (AST) 55 U/L, alanine aminotransferase (ALT) 95 U/L, total bilirubin 2.1 mg/dL, albumin 2.38 g/dL and CRP 22.81 mg/L. Cytomegalovirus (CMV) immunoglobulin (Ig) M, CMV DNA, Epstein-Barr virus (EBV)-VCA IgM, EBV DNA, human immunodeficiency virus (HIV) antibody (Ab), amebic Ab, Clostridium difficile toxin, culture forSalmonella,ShigellaandCampylobacterwere all negative. Positive CMV IgG, EBV-VCA IgG, stool pus stool and occult blood were noted.

        Imaging examinations

        Colonoscopy showed terminal ileal shallow ulcer (Figure 1A) and multiple complex rectal fistula tracts (Figure 1B and C) on 10thDecember 2019. Magnetic resonance imaging (MRI) noted decompensated liver cirrhosis with ascites (Figure 2A), rectoprostatic fistula (Figure 2B), rectopresacral fistula (Figure 2C) and pre-sacral abscess (Figure 2D) on 21thDecember 2019. Pathology revealed acute on chronic inflammation with granulation tissue, compactable with CD (Figure 3A). Besides, there was positive result of CMV immunohistochemistry (IHC) staining (Figure 3B), which was performed with a monoclonal antibody directed against the CMV pp65 antigen (Novocastra? lyophilized mouse monoclonal antibody; Leica Microsystems, Wetzlar, Germany).

        FINAL DIAGNOSIS

        He was diagnosed to have CD and CMV colitis by endoscopy and pathological findings. The CD activity index (CDAI) was 526 points and Harvey-Bradshaw index (HBI) was 22 points. He also had rectoprostatic fistula, rectopresacral fistula and presacral abscess diagnosed by MRI findings.

        TREATMENT

        He refused percutaneous abscess fine needle aspiration, and we kept Tazocin for abscess treatment for 27 d. Because of positive CMV IHC staining result, he also received intravenous ganciclovir for 17 d and then valganciclovir po treatment for two months. Transverse colostomy was performed for stool diversion on 25thDecember 2019. He couldn’t tolerant azathioprine due to pancytopenia and vedolizumab (300 mg 8 wk) was prescript since 22thJanuary 2020.

        OUTCOME AND FOLLOW-UP

        Follow-up sigmoidoscopy showed mucosal healing without any fistula tract (Figure 1D) on 9thJuly 2020. The pathologist reported minimal inflammatory activity (Figure 3C). Lower gastrointestinal series mentioned no more fistula tract (Figure 4) on 21thJuly 2020. There was no more rectoprostatic or rectopresacral fistula (Figure 5A) and pre-sacral abscess (Figure 5B) in MRI. After vedolizumab treatment for 6 mo, the CDAI was 42 points and HBI score was 0 point. His body weight body also increased 20 kg, back to the same level before the episode.

        DISCUSSION

        Figure 1 Endoscopic findings. A: Terminal ileal shallow ulcer at diagnosis; B and C: Multiple rectal fistula tracts with inflammation; D: Mucosal healing without fistula tracts six months after vedolizumab treatment, severe months after diagnosis.

        Fistulizing CD results in not only high morbidity but also impaired health-related quality of life[4]. Biologics combined with surgical intervention seems to be the best resolution. Although Infliximab has strongest evidence in fistulizing CD treatment[7,8], vedolizumab also showed its efficacy in some studies[5,6]. However, vedolizumab has better safety profiles (less severe adverse events and infections) in real world studies[9,10].

        Intra-abdominal abscess occurs in up to 20% of patients with CD[11,12]. Adequate percutaneous drainage combined with early adalimumab treatment achieves up to 74% successful rate[13]. In this case, it was difficult to drain the presacral abscess and patient refused, too. Therefore, we chose vedolizumab with transverse colostomy in treating the complex rectal fistula and presacral abscess without abscess drainage.

        This patient received vedolizumab treatment one month after confirmed the diagnosis. Earlier initiation of biological treatment shortly after diagnosis (less than one year) in patients with moderately to severely active CD leads to improved longterm clinical outcomes[14]. Besides, early stool diversion with transverse colectomy and early anti-viral treatment for CMV infection were crucial to achieve the good outcome in this case.

        CONCLUSION

        Vedolizumab with loop transverse colostomy was effective in treating CD with complex rectal fistulas with pre-sacral abscess. Besides, early biological and anti-CMV treatments might also lead to the favorable outcome.

        Figure 2 Magnetic resonance imaging at diagnosis. A-D: Liver cirrhosis (A) with ascites rectoprostaticfistula (B) rectopresacral fistula (C) with abscess presacral abscess (D).

        Figure 3 Patholog. A: Ulcer with acute on chronic inflammation and granulation tissue at diagnosis; B: Pathological presentations of cytomegalovirus (CMV) infection, immunohistochemistry stain (20 × objective) was performed with 1:200 diluted Novocastra? lyophilized mouse monoclonal antibody against CMV pp65 antigen and showed strong focal CMV immunoreactivity with brownish areas; C: Minimal inflammatory cells infiltration six months after vedolizumab treatment, severe months after diagnosis.

        Figure 4 Lower gastrointestinal series showed no more rectal fistula tract.

        Figure 5 Magnetic resonance imaging seven months after diagnosis. A: No more rectal fistula tract; B: No more pre-sacral abscess.

        日韩在线精品视频免费| 色老头在线一区二区三区| 亚洲AV色无码乱码在线观看| 国产精品国三级国产av| 日本女同视频一区二区三区| 性欧美丰满熟妇xxxx性久久久| 日本精品αv中文字幕| 国产精品11p| 亚洲区1区3区4区中文字幕码| 人妻少妇精品视频一区二区三| 好吊妞无缓冲视频观看| 丰满多毛少妇做爰视频| 国产成人自拍小视频在线| 日本视频一区二区三区在线观看| 国产偷久久久精品专区| 日韩精品无码区免费专区| 天堂av在线免费播放| 国内精品亚洲成av人片| 亚洲国产一区二区视频| 日产乱码一二三区别免费l| 欧美猛男军警gay自慰| 不卡国产视频| 亚洲精品熟女av影院| 五月av综合av国产av| 亚洲av无码一区二区三区网站| 娇妻粗大高潮白浆| 亚洲中文字幕久久精品色老板| 国产99久久久国产精品免费看| 亚洲大尺度在线观看| 在线亚洲国产一区二区三区| 美女视频黄是免费| 亚洲va中文字幕无码| 精品一区二区三区在线观看l| 国产一区二区三区亚洲| 亚洲国产色一区二区三区| 精品久久欧美熟妇www| 国精品无码一区二区三区在线看 | 精品人妻伦一二三区久久| 国产乱子乱人伦电影在线观看| 国产一起色一起爱| 国产一区二区精品人妖系列在线 |